John Everett remembers the drill. Every month-end, the CFO at Wray Community District Hospital & Clinics—a rural Colorado facility serving fewer than 5,000 people—would watch his team disappear into a maze of spreadsheets. Forty hours, sometimes sixty, just to figure out where the money was going. By the time they surfaced with answers, the data was already stale. Decisions that should have been made in real time came six months too late, if they came at all.
It's a scene playing out in finance departments across American healthcare. And it's the problem Translucent AI thinks it can solve with what amounts to a financial control tower for hospitals—one powered by the kind of AI agents that have been creeping into enterprise software over the past year.
On March 11, 2026, the New York-based startup announced it had raised $27 million in a Series A round led by Google Ventures. NEA, Virtue, and FPV Ventures all returned from the company's $7 million seed round announced the previous August. That's quick work in venture capital, particularly for a company selling into an industry not exactly known for rapid adoption of new technology.
But hospitals, it seems, are getting desperate.
The Numbers Don't Lie
Roughly 40% of U.S. health systems operated in the red in 2023, according to data from Kaufman Hall and the American Hospital Association. The pain concentrates where you'd expect: rural facilities, safety-net hospitals, anywhere that treats a lot of Medicaid patients. KFF's analysis found that 40% of critical access hospitals—small, often isolated facilities that serve as healthcare lifelines—lost money that year.
Meanwhile, the bigger picture keeps getting more expensive. American healthcare spending hit $5.3 trillion in 2024, still outpacing GDP growth with no signs of slowing. For hospital CFOs, the pressure isn't abstract. It shows up in budget meetings, in conversations with boards increasingly nervous about solvency, in the gap between what it costs to deliver care and what payers are willing to reimburse.
The irony? Most hospital finance teams are drowning in data. Electronic health records, enterprise resource planning systems, payroll platforms, payer contracts—all of them generate torrents of information. The challenge isn't getting data. It's making sense of it fast enough to actually do something about it.
What Translucent Is Building
Translucent's pitch is to become what CEO Jack O'Hara calls "healthcare's financial operating system." The platform pulls data from all those fragmented sources—EHRs, ERPs, payroll, contracts—and uses what the industry now calls agentic AI to monitor performance continuously. Not at month-end. Not when someone finally finishes the Excel pivot tables. All the time.
The system tracks six domains: claims processing, labor costs, clinical output, profit and loss, budgeting and forecasting, and contract economics. When something goes sideways—an unexpected spike in overtime, a payer denial trend, a service line bleeding more cash than projected—the platform flags it and suggests what to do about it.
O'Hara brings an unusual pedigree for a startup founder. He didn't come from Google or McKinsey. He spent years running technology inside health systems: CIO and chief transformation officer at Springfield Clinic, CIO at ChenMed, regional tech leadership at Mount Sinai. GV's investment memo, published alongside the funding announcement, pointed to that operator background as a key reason for the bet. It's one thing to build software for healthcare. It's another to have actually lived inside the chaos you're trying to fix.
Who's Buying In
So far, Translucent has signed Northwestern Medicine, Duly Health and Care, Wray Hospital & Clinic, and Springfield Clinic. John Orsini, CFO at Northwestern Medicine—one of the Midwest's largest academic health systems—said in a statement that the platform could "improve scale and visibility… where revenue and operational opportunities exist" by getting clinical and financial teams working off the same real-time data. It's the kind of measured endorsement CFOs tend to give, perhaps more enthusiastic in private.
Everett at Wray was more direct when he spoke to Fortune. What used to take his team 40 to 60 hours now happens in minutes, he said. "We're making real-time decisions instead of waiting six to twelve months."
Translucent claims its platform automates 97% of routine financial analysis and increases finance team capacity by 56%. Those are company-reported figures, not independently verified, so the usual caveats apply. But the company clearly has enough engagement with customers to feature them publicly—Orsini and Everett both appeared alongside O'Hara in a March 23 webinar hosted by Becker's Hospital Review, a healthcare trade publication.
The Road Ahead
The Series A money will go toward the predictable places: product development, hiring. Translucent lists seven open positions on its website, including roles for deployment leads, AI engineers, and—interestingly—healthcare actuaries. LinkedIn pegs the company at somewhere between 11 and 50 employees as of early March, though those figures often lag reality.
What Translucent didn't disclose: valuation, revenue, total customer count. The round was described as both preemptive and oversubscribed, which is startup-speak for "we had leverage," but without harder numbers it's tough to gauge just how much traction the company has beyond the marquee customer names. NEA, Virtue, and FPV clearly believe enough to double down. Redesign Health, a healthcare-focused startup studio, was also involved at the seed stage.
Whether Translucent can actually bend the curve on hospital margins remains an open question. Healthcare has seen plenty of tech promises that didn't quite deliver, plenty of platforms that worked in theory but foundered on implementation. But the market pressure is real. And for CFOs like Everett, staring down another month-end close with a skeleton crew and an ocean of spreadsheets, even an incremental improvement starts to look like salvation.
